NewAmsterdam Pharma Co NV (FRA:KH6) Long-Term Capital Lease Obligation : €0.00 Mil (As of Dec. 2023)

View and export this data going back to 2022. Start your Free Trial

What is NewAmsterdam Pharma Co NV Long-Term Capital Lease Obligation?

NewAmsterdam Pharma Co NV's Long-Term Capital Lease Obligation for the quarter that ended in Dec. 2023 was €0.00 Mil.

NewAmsterdam Pharma Co NV's quarterly Long-Term Capital Lease Obligation declined from Dec. 2022 (€0.06 Mil) to Jun. 2023 (€0.02 Mil) and declined from Jun. 2023 (€0.02 Mil) to Dec. 2023 (€0.00 Mil).

NewAmsterdam Pharma Co NV's annual Long-Term Capital Lease Obligation declined from Dec. 2021 (€0.11 Mil) to Dec. 2022 (€0.06 Mil) and declined from Dec. 2022 (€0.06 Mil) to Dec. 2023 (€0.00 Mil).

NewAmsterdam Pharma Co NV Long-Term Capital Lease Obligation Historical Data

The historical data trend for NewAmsterdam Pharma Co NV's Long-Term Capital Lease Obligation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

NewAmsterdam Pharma Co NV Long-Term Capital Lease Obligation Chart

NewAmsterdam Pharma Co NV Annual Data

Trend

Dec20

Dec21

Dec22

Dec23

Long-Term Capital Lease Obligation

0.11

0.06

NewAmsterdam Pharma Co NV Semi-Annual Data
	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Long-Term Capital Lease Obligation	Get a 7-Day Free Trial			0.11	0.09	0.06	0.02	-

NewAmsterdam Pharma Co NV (FRA:KH6) Long-Term Capital Lease Obligation Explanation

Long-Term Capital Lease Obligation are the amount due for long-term asset lease agreements that are nearly equivalent to asset purchases. Capital lease obligations are installment payments that constitute a payment of principal plus interest for the capital lease. The Short-Term Capital Lease Obligation is the portion of a Long-Term Capital Lease Obligation that is due over the next year.

Under US Generally Accepted Accounting Principles (GAAP), a capital lease is essentially equivalent to a purchase by the lessee if it meets the following criteria:

1. Ownership of the asset is transferred to the lessee at the end of the lease term;
2. The lease contains a bargain purchase option to buy the equipment at less than fair market value;
3. The lease term equals or exceeds 75% of the asset's estimated useful life;
4. The present value of the lease payments equals or exceeds 90% of the total original cost of the equipment.

NewAmsterdam Pharma Co NV Long-Term Capital Lease Obligation Related Terms

Thank you for viewing the detailed overview of NewAmsterdam Pharma Co NV's Long-Term Capital Lease Obligation provided by GuruFocus.com. Please click on the following links to see related term pages.

NewAmsterdam Pharma Co NV (FRA:KH6) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » NewAmsterdam Pharma Co NV (FRA:KH6) » Definitions » Long-Term Capital Lease Obligation

Comparable Companies

Traded in Other Exchanges

NAMS:USA KH6:Germany

Address

Gooimeer 2-35, Naarden, NH, NLD, 1411 DC

Website

https://www.newamsterdampharma.com

NewAmsterdam Pharma Co NV is a clinical-stage company focused on the research and development of transformative therapies for metabolic diseases and Alzheimer's disease.

NewAmsterdam Pharma Co NV (FRA:KH6) Headlines

No Headlines